Boyle A. Uniform addition of ribavirin to sofosbuvir/velpatasvir for genotype 3 patients with cirrhosis: real world outcomes. THU-285.
Verhoogd risico op pancreascarcinoom na HCV-infectie
dec 2025 | Hepatitis, Maag-darm-leveroncologie, Virale infecties